{"id":"012b0b52-17af-4d30-9e8c-80a80b69a5ef","kind":"news","code":"012b0b52-17af-4d30-9e8c-80a80b69a5ef","name":"Superluminal Medicines raises USD 120 million in Series A financing","nameBasis":"translated-title","summary":"","description":"","country":null,"category":null,"originalName":"Superluminal Medicines完成1.2亿美元A轮融资","eventDate":"2024-09-09T00:00:00.000Z","website":null,"sourceUpdatedAt":"2026-10-15T09:54:27.118Z","englishUpdatedAt":"2026-10-15T17:19:59.178Z","reviewedAt":"2026-10-15T17:19:59.178Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"dad4fa4c64ac255cdb6fbb7b3cdf1ed0bfd304e3c8f6cb55d15dd5d95c6b3db7","companyId":"7c66c728-c0c9-4716-992b-f0a5fc8d890e","foundedYear":null,"logoUrl":null,"originalText":"","sources":[],"related":[{"id":"95d6af86-e104-4512-be32-a32ef1a9ac68","kind":"institutions","code":"UB-I145","name":"Catalio Capital Management","nameBasis":"original-brand","summary":"An investment firm focused on life sciences and healthcare.","description":"An investment firm focused on life sciences and healthcare.","country":null,"category":null,"originalName":"Catalio Capital Management","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-14T10:56:17.814Z","englishUpdatedAt":"2026-10-15T20:40:58.165Z","reviewedAt":"2026-10-15T20:40:58.165Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"3681c48034ed8b622dceabf6c91f2d394b390b9f30292e4a1f99e80c60a8a4bb","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/catalio-capital-management"},{"id":"479a9c91-684c-48df-b111-80fcf5f8783a","kind":"institutions","code":"UB-I541","name":"Cooley","nameBasis":"original-brand","summary":"Investment affiliated with Cooley law firm.","description":"Investment affiliated with Cooley law firm.","country":null,"category":null,"originalName":"Cooley","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-14T10:46:24.028Z","englishUpdatedAt":"2026-10-15T20:13:55.852Z","reviewedAt":"2026-10-15T20:13:55.852Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"772229fe471c72f1f340b75bffafcb026b460730e3de5107226ac2b557a6b49b","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/cooley"},{"id":"c4d6bbd2-be93-4c8c-b3f8-670870244af3","kind":"institutions","code":"UB-I5537","name":"Eli Lilly","nameBasis":"original-brand","summary":"Eli Lilly is a U.S. corporate investment platform making strategic investments in growth-stage and mature companies.","description":"Eli Lilly is a U.S. corporate investment platform making strategic investments in growth-stage and mature companies.","country":null,"category":null,"originalName":"Eli Lilly","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T12:06:27.642Z","englishUpdatedAt":"2026-10-15T17:35:39.708Z","reviewedAt":"2026-10-15T17:35:39.708Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"be93211139cb262dbad90ea7ccc8c5ac919d18487ec4a37a8730a93ad0d87add","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/eli-lilly"},{"id":"889bf577-45e9-4bcf-8a86-448147e2d494","kind":"institutions","code":"UB-I926","name":"Eli Lilly and Company","nameBasis":"original-brand","summary":"Strategic investment division of multinational pharmaceutical company Eli Lilly.","description":"Strategic investment division of multinational pharmaceutical company Eli Lilly.","country":null,"category":null,"originalName":"Eli Lilly and Company","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:56:19.540Z","englishUpdatedAt":"2026-10-15T20:18:30.627Z","reviewedAt":"2026-10-15T20:18:30.627Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"c411259d2de066409798e6f87bf1d3b438ae59378de955dfc1da3a5f335c73c9","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/eli-lilly-and-company"},{"id":"3409c90e-a603-48b3-b175-6b6608175f4e","kind":"institutions","code":"UB-I838","name":"Gaingels","nameBasis":"original-brand","summary":"A well-known US angel co-investment syndicate network.","description":"A well-known US angel co-investment syndicate network.","country":null,"category":null,"originalName":"Gaingels","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-14T11:22:30.011Z","englishUpdatedAt":"2026-10-15T21:02:48.735Z","reviewedAt":"2026-10-15T21:02:48.735Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"e414fb5d0309c7ea8cc69b8ec7ac0149096a186a3ed83242bca8fb660d4791fd","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/gaingels"},{"id":"10eab593-16d3-4f37-ae9c-64d51d8a9475","kind":"institutions","code":"UB-I043","name":"Insight Partners","nameBasis":"original-brand","summary":"A globally prominent growth-stage venture capital firm in software and SaaS, focused on high-growth technology enterprises.","description":"A globally prominent growth-stage venture capital firm in software and SaaS, focused on high-growth technology enterprises.","country":null,"category":null,"originalName":"Insight Partners","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-14T11:22:28.736Z","englishUpdatedAt":"2026-10-15T21:38:48.439Z","reviewedAt":"2026-10-15T21:38:48.439Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"f4565a4fbf5ccce8d45edcc38b4e9ca6483d45a13dafad48a0f5844df2121da1","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/insight-partners"},{"id":"bb3a0968-c147-4064-86ac-f87a6b2c3336","kind":"institutions","code":"UB-I084","name":"NVIDIA","nameBasis":"original-brand","summary":"NVIDIA's strategic investment division, focused on enterprises in AI, GPU computing, and related ecosystems.","description":"NVIDIA's strategic investment division, focused on enterprises in AI, GPU computing, and related ecosystems.","country":null,"category":null,"originalName":"NVIDIA","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-14T11:22:28.514Z","englishUpdatedAt":"2026-10-15T21:37:02.777Z","reviewedAt":"2026-10-15T21:37:02.777Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"8a62c3d17681228b0f2100d52b9d441c8cbf7cd76ff11e3f9d0dc9bf9d6cb200","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/nvidia"},{"id":"84cacc56-8b65-4ff8-a7ba-456e915dddae","kind":"institutions","code":"UB-I3822","name":"RA Capital Management","nameBasis":"original-brand","summary":"Investment firm focused on biotechnology and healthcare.","description":"Investment firm focused on biotechnology and healthcare.","country":null,"category":null,"originalName":"RA Capital Management","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T17:04:13.435Z","englishUpdatedAt":"2026-10-15T18:45:27.783Z","reviewedAt":"2026-10-15T18:45:27.783Z","snapshotAt":"2026-10-15T18:31:23.182Z","sourceHash":"9efdf935b1711e3645661d73e90bdd347cea2120ff6751766a951bcbbdce77ec","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/ra-capital-management"},{"id":"7c66c728-c0c9-4716-992b-f0a5fc8d890e","kind":"companies","code":"UB-C7640","name":"Superluminal Medicines","nameBasis":"source-english","summary":"","description":"","country":"United States","category":null,"originalName":"Superluminal Medicines","eventDate":null,"website":"https://www.superluminalrx.com/","sourceUpdatedAt":"2026-10-08T00:00:00.000Z","englishUpdatedAt":"2026-10-16T01:39:37.479Z","reviewedAt":"2026-10-16T01:39:37.479Z","snapshotAt":"2026-10-16T01:37:30.476Z","sourceHash":"474e300951aa7870f062ba3b20ac3c2c5752f48a19f668fad295bd5d0edc3d32","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/companies/superluminal-medicines"}],"path":"/news/012b0b52-17af-4d30-9e8c-80a80b69a5ef","structured":{"city":null,"country":null,"location":null,"role":null,"category":null,"company":{"name":"Superluminal Medicines","path":"/companies/superluminal-medicines"}},"canonical":"https://uniquebase.ai/news/012b0b52-17af-4d30-9e8c-80a80b69a5ef"}